INVO Fertility Inc (IVF) concluded trading on Wednesday at a closing price of $2.39, with 82.19 million shares of worth about $196.43 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -76.25% during that period and on April 30, 2025 the price saw a gain of about 48.45%. Currently the company’s common shares owned by public are about 0.67M shares, out of which, 0.57M shares are available for trading.
Stock saw a price change of 24.48% in past 5 days and over the past one month there was a price change of 19.50%. Year-to-date (YTD), IVF shares are showing a performance of -75.41% which decreased to -79.68% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.38 but also hit the highest price of $17.04 during that period. The average intraday trading volume for INVO Fertility Inc shares is 114.35K. The stock is currently trading 22.07% above its 20-day simple moving average (SMA20), while that difference is down -14.71% for SMA50 and it goes to -68.16% lower than SMA200.
INVO Fertility Inc (NASDAQ: IVF) currently have 0.67M outstanding shares and institutions hold larger chunk of about 16.31% of that.
The stock has a current market capitalization of $1.59M and its 3Y-monthly beta is at 2.32. It has posted earnings per share of -$30.54 in the same period. It has Quick Ratio of 0.27 while making debt-to-equity ratio of 3.96. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for IVF, volatility over the week remained 29.82% while standing at 22.87% over the month.
Analysts are in expectations that INVO Fertility Inc (IVF) stock would likely to be making an EPS of 0 in the current quarter, while forecast for next quarter EPS is 0 and it is -0.98 for next year. For the current quarter EPS, analysts have given the company a lowest target 0 which is 0 at the higher side of the target for the same. Stock’s fiscal year EPS is expected to rise by 96.32% while it is estimated to increase by 11.71% in next year. EPS is likely to grow at an annualized rate of 60.65% for next 5-years, compared to annual growth of 17.42% made by the stock over the past 5-years.
